AR019703A1 - NEUROPROTECTOR COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF NERVOUS ALTERATIONS AND BEHAVIOR DUE TO STATES OF ANXIETY OR DEPRESSION - Google Patents

NEUROPROTECTOR COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF NERVOUS ALTERATIONS AND BEHAVIOR DUE TO STATES OF ANXIETY OR DEPRESSION

Info

Publication number
AR019703A1
AR019703A1 ARP990103007A AR019703A1 AR 019703 A1 AR019703 A1 AR 019703A1 AR P990103007 A ARP990103007 A AR P990103007A AR 019703 A1 AR019703 A1 AR 019703A1
Authority
AR
Argentina
Prior art keywords
anxiety
nervous
prevention
composition
depression
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT98RM000425A external-priority patent/IT1299195B1/en
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of AR019703A1 publication Critical patent/AR019703A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describe una composicion para la prevencion y/o tratamiento terapéutico de alteraciones nerviosas y del comportamiento debidas a estados de ansiedad odepresion que tienen la forma de un suplemento dietético, un soporte dietético o de un medicamento, que comprende como ingredientes activos caracterizantesacetil L-carnitina e hipericina.A composition for the prevention and / or therapeutic treatment of nervous and behavioral alterations due to anxiety or depression states that have the form of a dietary supplement, a dietary support or a medicament, comprising as active active ingredients acetyl L-carnitine is described. and hypericin.

ARP990103007 1998-06-25 1999-06-23 NEUROPROTECTOR COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF NERVOUS ALTERATIONS AND BEHAVIOR DUE TO STATES OF ANXIETY OR DEPRESSION AR019703A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRN980425 1998-06-25
IT98RM000425A IT1299195B1 (en) 1998-06-25 1998-06-25 COMPOSITION WITH NEUROPROTECTIVE ACTIVITY FOR THE PREVENTION AND TREATMENT OF STATE-RELATED NERVOUS AND BEHAVIORAL ALTERATIONS

Publications (1)

Publication Number Publication Date
AR019703A1 true AR019703A1 (en) 2002-03-13

Family

ID=45569883

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103007 AR019703A1 (en) 1998-06-25 1999-06-23 NEUROPROTECTOR COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF NERVOUS ALTERATIONS AND BEHAVIOR DUE TO STATES OF ANXIETY OR DEPRESSION

Country Status (1)

Country Link
AR (1) AR019703A1 (en)

Similar Documents

Publication Publication Date Title
BR9909903A (en) Maximum effectiveness of substances used to improve health and well-being
AR022076A1 (en) ANTIOXIDANT COMPOSITION CONSTITUTED BY L-CARNITINE OIL AND ALPHA-LIPOIC ACID TO IMPROVE METABOLIC USE OF GLUCOSE
AR026610A1 (en) A PIRROLIDINACETAMIDE DERIVATIVE ONLY OR IN COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
AR018924A1 (en) COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF OSTEOPOROSIS AND ALTERATIONS DUE TO THE MENOPAUSE SYNDROME
BR9912179A (en) Neuroprotective composition for the prevention and / or treatment of nervous and behavioral changes due to states of anxiety or depression
BR9715022A (en) Method for treating prostate disease using systematic and / or prolonged release of vitamin D formulations
AR054139A1 (en) MODIFIED FORMATION AND IMMEDIATE RELEASE OF MEMANTINE SPHERES
RS52781B (en) Agents for preventing and treating disorders involving modulation of the ryr receptors
AR025111A1 (en) METHODS AND COMPOSITIONS TO TREAT GENERALIZED ANXIETY DISORDERS
AR049518A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING A SILICONE AGENT AND TWO SOLUBILIZED ACTIVE PRINCIPLES
AR077573A2 (en) USE OF A TNF INHIBITOR AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
BRPI0414876A (en) pharmaceutical compounds and compositions for the prevention of overdose or abuse and their uses
ATE456369T1 (en) FLIBANSERIN FOR THE TREATMENT OF URINARY INCONTINENCE AND ASSOCIATED DISEASES
AR054249A1 (en) TREATMENT OF SKIN CONNECTIVE TISSUE DISEASES
PT1411938E (en) USE OF CYCLOPAMINE FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF PSORIASIS
BR0309837A (en) Trans-epicutaneous administration form for the treatment of restless leg syndrome
RS52867B (en) Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
AR028959A1 (en) USE OF RAPAMYCIN FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT CARDIOVASCULAR DISEASES
BR0006024A (en) Composition for the treatment of inflammation and pain in mammals
BR0209327A (en) Composition for treatment of drug-induced constipation
AR052152A1 (en) PHARMACEUTICAL PRODUCT FOR THE PREVENTIVE AND THERAPEUTIC TREATMENT OF SUENO DISORDERS
AR023391A1 (en) COMPOSITION CONTAINING CARNITINE AND INOSITOL PHOSPHATE, USEFUL AS A DIETARY SUPPLEMENT OR DRUG
ES2195939T3 (en) COMPOSITION FOR PREVENTION AND / OR TREATMENT OF CIRCULATORY DISORDERS THAT INCLUDES DERIVATIVES OF L-CARNITINE AND GINKGO BILOBA EXTRACTS.
BR0310061A (en) Methods for treating respiratory diseases and conditions with a selective inhibitor of inos and a inhibitor of pde and their compositions
AR048806A1 (en) USE OF CARIOFILENES IN THE PREPARATION OF MEDICINES AND TREATMENT OF BODY INFLAMMATION AND INFLAMMATORY PAIN AFFECTIONS

Legal Events

Date Code Title Description
FB Suspension of granting procedure